Ventana Medical Systems
Nathaniel Hart, Ph.D., is a Senior Scientist at Roche since March 2021, where previous roles included Scientist and Medical Writer. Prior to Roche, Nathaniel served as an Assistant Research Scientist at the University of Arizona College of Medicine – Tucson from July 2018 to March 2021 and completed a Postdoctoral Research Fellowship at Vanderbilt University Medical Center from July 2013 to July 2018. Nathaniel began their professional journey as an Education Volunteer with the Peace Corps from September 2005 to December 2007. Academically, Nathaniel earned a Doctor of Philosophy (Ph.D.) in Physiology from the University of Arizona College of Medicine – Tucson in 2013 and holds a Bachelor’s Degree in Physiology from the University of Arizona, with additional studies at the University of Oregon during 2003-2004.
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.